Showing results (51-60 of 107) with videos related to

Sort By:
Pageof 11
Blood|June 10, 2022
Quercetin ameliorates XIAP deficiency-associated hyperinflammationSamuel C C Chiang, Erika Owsley, Neelam Panchal, et al.
British Journal of Haematology|October 24, 2006
CD34 stem cell top-ups without conditioning after initial haematopoietic stem cell transplantation for correction of incomplete haematopoietic and immunological recovery in severe congenital immunodeficienciesClaire Booth, Jean-Antoine Ribeil, Françoise Audat, et al.
Clinical Immunology (Orlando, Fla.)|April 3, 2022
Preemptive hematopoietic cell transplantation for asymptomatic patients with X-linked lymphoproliferative syndrome type 1Dan Tomomasa, Claire Booth, Jack J Bleesing, et al.
Journal of Clinical Immunology|November 28, 2024
Griscelli Syndrome Type 2: Comprehensive Analysis of 149 New and Previously Described Patients with RAB27A DeficiencyJesmeen Maimaris, Adriel Roa-Bautista, Mahreen Sohail, et al.
Gene Therapy|June 14, 2020
Lentiviral gene therapy rescues p47<sup>phox</sup> chronic granulomatous disease and the ability to fight Salmonella infection in miceAndrea Schejtman, Walmir Cutrim Aragão-Filho, Simon Clare, et al.
Immunity, Inflammation and Disease|December 30, 2025
Functional Characterization of an IL2RG Variant, a Case Report of X-Linked T- B + NK + SCIDKristian Assing, Emil Birch Christensen, Christoffer Dellgren, et al.
Nature Communications|March 13, 2021
Long-term lymphoid progenitors independently sustain naïve T and NK cell production in humansNatalia Izotova, Christine Rivat, Cristina Baricordi, et al.
Pediatric Blood & Cancer|October 19, 2023
Busulfan and subsequent malignancy: An evidence-based risk assessmentJanel R Long-Boyle, Donald B Kohn, Ami J Shah, et al.
The Journal of Allergy and Clinical Immunology|December 17, 2021
Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiencyLinlin Yang, Claire Booth, Carsten Speckmann, et al.
Molecular Therapy. Methods & Clinical Development|July 1, 2024
Design and validation of a GMP stem cell manufacturing protocol for MPSII hematopoietic stem cell gene therapyStuart Ellison, Karen Buckland, Yuko Learmonth, et al.
Pageof 11